Latest period
$22.2B
YoY change
-7.9%
5Y CAGR
-4.8%
Peak year (FY2017)
$33.5B
Latest annual
$24.6B
Total Debt history chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: $24.6B
Total Debt growth chart for Gilead Sciences (GILD) from 2016 to 2025
Latest: -7.9%
Total Debt history table for Gilead Sciences (GILD) from 1991 to 2025
| FY2025 | $24.6B | -7.9% | -$2.12B | ||
| FY2024 | $26.7B | +6.9% | +$1.72B | ||
| FY2023 | $25B | -1.0% | -$243M | ||
| FY2022 | $25.2B | -5.5% | -$1.47B | ||
| FY2021 | $26.7B | -15.0% | -$4.71B | ||
| FY2020 | $31.4B | +27.7% | +$6.81B | ||
| FY2019 | $24.6B | -10.0% | -$2.73B | ||
| FY2018 | $27.3B | -18.5% | -$6.22B | ||
| FY2017 | $33.5B | +27.3% | +$7.2B | ||
| FY2016 | $26.3B | +19.5% | +$4.29B | ||
| FY2015 | $22.1B | +77.8% | +$9.65B | ||
| FY2014 | $12.4B | +86.9% | +$5.77B | ||
| FY2013 | $6.64B | -19.3% | -$1.59B | ||
| FY2012 | $8.22B | +8.1% | +$617M | ||
| FY2011 | $7.61B | +118.3% | +$4.12B | ||
| FY2010 | $3.48B | +177.9% | +$2.23B | ||
| FY2009 | $1.25B | +8.1% | +$93.8M | ||
| FY2008 | $1.16B | -11.6% | -$152M | ||
| FY2007 | $1.31B | -7.0% | -$98.7M | ||
| FY2006 | $1.41B | +368.9% | +$1.11B | ||
| FY2005 | $301M | +72395.4% | +$300M | ||
| FY2004 | $415K | -99.9% | -$345M | ||
| FY2003 | $345M | -42.0% | -$250M | ||
| FY2002 | $595M | +136.4% | +$344M | ||
| FY2001 | $252M | -1.3% | -$3.39M | ||
| FY2000 | $255M | +190.2% | +$167M | ||
| FY1999 | $88M | -13.3% | -$13.5M | ||
| FY1998 | $102M | +3071.9% | +$98.3M | ||
| FY1997 | $3.2M | -50.8% | -$3.3M | ||
| FY1996 | $6.5M | +1.6% | +$100K | ||
| FY1995 | $6.4M | -23.8% | -$2M | ||
| FY1994 | $8.4M | — | — | ||
| FY1992 | $1.8M | +80.0% | +$800K | ||
| FY1991 | $1M | +25.0% | +$200K | ||
| FY1990 | $800K | — | — |
- FY2025$24.6B-7.9%
- FY2024$26.7B+6.9%
- FY2023$25B-1.0%
- FY2022$25.2B-5.5%
- FY2021$26.7B-15.0%
- FY2020$31.4B+27.7%
- FY2019$24.6B-10.0%
- FY2018$27.3B-18.5%
- FY2017$33.5B+27.3%
- FY2016$26.3B+19.5%
- FY2015$22.1B+77.8%
- FY2014$12.4B+86.9%
- FY2013$6.64B-19.3%
- FY2012$8.22B+8.1%
- FY2011$7.61B+118.3%
- FY2010$3.48B+177.9%
- FY2009$1.25B+8.1%
- FY2008$1.16B-11.6%
- FY2007$1.31B-7.0%
- FY2006$1.41B+368.9%
- FY2005$301M+72395.4%
- FY2004$415K-99.9%
- FY2003$345M-42.0%
- FY2002$595M+136.4%
- FY2001$252M-1.3%
- FY2000$255M+190.2%
- FY1999$88M-13.3%
- FY1998$102M+3071.9%
- FY1997$3.2M-50.8%
- FY1996$6.5M+1.6%
- FY1995$6.4M-23.8%
- FY1994$8.4M—
- FY1992$1.8M+80.0%
- FY1991$1M+25.0%
- FY1990$800K—
Total Debt values are taken from Gilead Sciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported total debt is $22.2B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) total debt totalled $24.6B – declined 7.9% year-over-year.
Through 2020–2025 (5 years), Gilead Sciences total debt delivered a -4.8% annualised rate; with a net decline across the window.
The record annual total debt stands at $33.5B, reached in 2017; the historical low of $415K was recorded in 2004.
Gilead Sciences Total Debt by Year
Gilead Sciences Total Debt 2025: $24.6B
Gilead Sciences posted total debt of $24.6B in 2025, declined 7.9% below 2024.
Gilead Sciences Total Debt 2024: $26.7B
In 2024, Gilead Sciences reported total debt of $26.7B, grew 6.9% from 2023.
Gilead Sciences Total Debt 2023: $25B
Gilead Sciences total debt in 2023 was $25B, edged down 1.0% below 2022.
Gilead Sciences Total Debt 2022: $25.2B
2022's total debt for Gilead Sciences came in at $25.2B, declined 5.5% below 2021.
Gilead Sciences Total Debt 2021: $26.7B
Gilead Sciences total debt in 2021 was $26.7B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Total Debt
Healthcare peers of Gilead Sciences (GILD), ranked by their latest total debt
| $78.4B | |
| $69.1B | |
| $54.6B | |
| $50.5B | |
| $47.9B | |
| $42.5B | |
| $40.9B | |
| $20.6B |
- $78.4B
- $69.1B
- $54.6B
- $50.5B
- $47.9B
- $42.5B
- $20.6B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.43% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.